Skip to main content
Clinical Trials/CTRI/2010/091/002947
CTRI/2010/091/002947
Completed
Phase 3

A randomized comparative study evaluating the efficacy and tolerability of a 1000 IU/ml topical solution of heparin sodium as compared to a 200 IU/G heparin sodium gel in the management of post infusion superficial thrombophlebitis.

Troikaa Pharmaceuticals Ltd0 sites200 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Post infusion superficial thrombophlebitis.
Sponsor
Troikaa Pharmaceuticals Ltd
Enrollment
200
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • a)Patients in the age group of 18\-60 years
  • b)Patients of both sexes
  • c)Patients on IV infusion
  • d)Superficial thrombophlebitis Grade 2\-4

Exclusion Criteria

  • a)Patients below 18 years and above 60 years of age
  • b)Patients on anticoagulants
  • c)Pregnant and lactating women
  • d)Patients with any contraindication to heparin
  • e)Mentally retarded patients
  • f)Unwilling patients
  • g)Patients with known hypersensitivity to any component of the formulation
  • h)Patients with grade 1 or 5 phlebitis
  • i)Application of other topical anti\-inflammatory agent.

Outcomes

Primary Outcomes

Not specified

Similar Trials